Misoprostol for intrauterine device placement.

Area of Science:

• Reproductive Health
• Gynecology
• Clinical Trials

Background:

• Intrauterine device (IUD) placement can be associated with pain and technical challenges for providers.
• Misoprostol is investigated for its potential to soften the cervix, easing IUD insertion and reducing pain.

Purpose of the Study:

• To evaluate the efficacy of misoprostol in improving patient and provider outcomes during routine IUD placement compared to placebo or no treatment.

Main Methods:

• Systematic review and meta-analysis of 14 randomized controlled trials (RCTs) involving 1972 women undergoing interval IUD placement.
• Outcomes assessed included pain, ease of placement, cervical dilation, success rates, patient satisfaction, and adverse events.
• GRADE methodology was used to assess the certainty of evidence.

Main Results:

• Misoprostol showed little to no difference in pain during tenaculum placement and after IUD insertion (high-certainty evidence).
• It had little to no effect on providers' ease of placement, need for cervical dilation, or overall placement success, except for a probable increase in success for women with a recent failed IUD attempt.
• Misoprostol use was associated with a probable increase in preplacement abdominal pain/cramping and diarrhea, with very uncertain evidence for increased patient satisfaction.

Conclusions:

• For routine IUD placement, misoprostol offers minimal benefits regarding pain reduction or improved provider ease, with probable increases in side effects.
• A potential benefit for placement success exists for women with a recent failed IUD attempt, but this must be weighed against increased adverse effects.
• Further research is needed to explore effect modifiers, as current evidence is limited.